Target intelligence / Profile preview

Potassium ion concentration in extracellular fluid

Molecular classification
Other
01

Overview

The potassium ion concentration in extracellular fluid refers to the precise amount of potassium ions (K^+) present outside cells in body fluids, particularly in plasma and interstitial fluid. Normally, potassium is the major intracellular cation, with only about 2% found in the extracellular compartment, where the concentration is tightly regulated between 3.5 and 5 mmol/L[5][6]. This parameter is crucial for maintaining the resting membrane potential of excitable tissues like nerve and muscle and for ensuring proper function of cellular processes such as action potential generation, muscle contraction, and acid-base balance[2][5][7]. Potassium concentration is dynamically controlled by the sodium-potassium ATPase, renal excretion, hormonal influences (insulin, aldosterone), and acid-base status[5][7]. Disturbances in extracellular potassium can have serious physiological consequences, notably affecting cardiac and neuromuscular function[5]. Changes in this concentration are not properties of a molecular target, but represent a key measurable variable in physiology and medicine rather than a discrete drug target or molecular entity[5][6][7].

Other names
extracellular potassium concentrationextracellular K+plasma potassium
02

Mechanism of action

Drugs affect potassium excretion or reabsorption (diuretics increase excretion; potassium-sparing diuretics decrease excretion) Insulin promotes cellular uptake of potassium by stimulating Na^+/K^+-ATPase ACE inhibitors and ARBs decrease aldosterone, reducing potassium excretion

03

Biological functions

Maintenance of resting membrane potentialNerve impulse transmissionMuscle contractionOsmotic balanceAcid-base homeostasis
04

Disease associations

Cardiovascular disease (e.g., arrhythmia)Renal diseaseNeuromuscular disordersMetabolic disorders
05

Safety considerations

Risk of hyperkalemia (leading to cardiac arrhythmias, cardiac arrest)Risk of hypokalemia (leading to muscle weakness, arrhythmias, paralysis)Fluctuations from drugs, renal dysfunction, or metabolic disturbances
06

Interacting drugs

Diuretics (e.g., furosemide, thiazides)

5 more in the full profile.

07

Biomarkers

Serum potassium concentration (measured in mmol/L)Electrocardiogram (EKG) changes associated with hypo- or hyperkalemia

Beyond the preview

Go deeper on Potassium ion concentration in extracellular fluid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium ion concentration in extracellular fluid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call